ctrl K

Oruka Therapeutics Inc. (ORKA)

10.28

0.19 (1.88%)

At close: Apr 28, 2025, 3:59 PM

10.28

0.00%

After-hours: Apr 28, 2025, 04:05 PM EDT

Oruka Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	16K	n/a	n/a	19K	23K	30K	29K	29K
Gross Profit	-16K	n/a	n/a	-19K	-23K	-30K	-29K	-29K
Operating Income	-30.32M	-29.45M	n/a	-2.48M	-1.59M	-1.94M	-1.97M	-1.8M
Interest Income	4.53M	1.33M	n/a	473K	501K	513K	493K	450K
Pretax Income	-25.78M	-28.62M	n/a	-2.01M	-1.09M	-1.42M	-1.48M	-1.35M
Net Income	-25.78M	-28.62M	n/a	-2.01M	-1.09M	-1.42M	-1.48M	-1.35M
Selling & General & Admin	4.8M	3.76M	n/a	2.3M	1.52M	1.58M	1.69M	1.38M
Research & Development	25.5M	25.69M	n/a	165K	47K	322K	254K	390K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	30.3M	29.45M	n/a	2.46M	1.57M	1.91M	1.94M	1.77M
Interest Expense	n/a	504K	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	30.32M	29.45M	n/a	2.48M	1.59M	1.94M	1.97M	1.8M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	16.79M	15.01M	1.21M	1.21M	1.21M	1.2M	1.2M	1.2M
Shares Outstanding (Diluted)	16.79M	15.01M	1.21M	1.21M	1.21M	1.2M	1.2M	1.2M
EPS (Basic)	-1.54	-1.91	n/a	-1.66	-0.9	-1.19	-1.23	-1.12
EPS (Diluted)	-1.54	-1.91	n/a	-1.66	-0.9	-1.19	-1.23	-1.12
EBITDA	-25.77M	-28.12M	n/a	-1.99M	-1.07M	-1.39M	-1.45M	-1.32M
EBIT	-25.78M	-28.12M	n/a	-2.01M	-1.09M	-1.42M	-1.48M	-1.35M
Depreciation & Amortization	16K	n/a	n/a	19K	23K	30K	29K	29K